News

Shorter chemotherapy course ‘equally effective’ in diffuse large B-cell lymphoma

Reducing administration of CHOP chemotherapy by two cycles appeared as effective as the standard six cycles for younger patients with low-risk diffuse large B-cell lymphoma, according to results of the phase 3 FLYER trial presented at ASH Annual Meeting and Exposition. Andre Goy, M.D., M.S., John Theurer Cancer Center, Hackensack University Medical Center provides perspective. Additional stories in Healio: Single tisagenlecleucel infusion yields durable response in acute lymphoblastic leukemia, Checkpoint inhibitors enhance CAR T-cell therapy in relapsed B-cell acute lymphoblastic leukemia

READ FULL ARTICLE ON URLDEFENSE.PROOFPOINT.COM